SAN DIEGO, Calif.--(BUSINESS WIRE)--Avenzo Therapeutics, Inc. (“Avenzo”), a clinical-stage biotechnology company developing next-generation oncology therapies, today reported initial clinical data ...
Avenzo Therapeutics, Inc. (“Avenzo”), a clinical-stage biotechnology company developing next-generation oncology therapies, today reported initial clinical data from the Phase 1 portion of its ongoing ...
Avenzo Therapeutics Presents Initial Results from the Phase 1/2 Study of AVZO-021, a Potential Best-in-Class CDK2 Inhibitor, at the 2025 San Antonio Breast Cancer Symposium Avenzo Therapeutics, Inc. ( ...
Angiopoietin-like protein 3 (ANGPTL3) inhibits lipoprotein and endothelial lipases. ANGPTL3 loss-of-function genetic variants are associated with decreased levels of low-density lipoprotein ...
The extension will also add a new bridge, tunnel and four stations. Jacobs was selected to lead Phase 1 for Sound Transit’s West Seattle Link Extension project, which will expand the city of Seattle’s ...
RG6501 (OpRegen) cell therapy shows sustained visual acuity and retinal structure improvements in GA patients over 36 months. Extensive coverage of OpRegen therapy leads to greater BCVA and retinal ...
Eli Lilly has shared phase 1 data on amylin analog eloralintide, impressing analysts with results that point to the potential for the drug candidate to form part of a market-leading Zepbound ...
New survival horror game Phase Zero debuted its free demo on Steam on May 26, 2025, and has been overwhelmingly well-received. Developed by SPINA Studio, an indie team of experienced developers, and ...
TIX100 Demonstrates Safety and Tolerability in Human Subjects, Marking a Key Drug Development Milestone Post-Hoc Analysis Reveals Promising First Biological TIX100 Signal in Humans TIXiMED to Advance ...
You won’t be going to Capital One Arena for a few months, because the home of the Washington Wizards and Capitals will be closed for the first phase of its massive remodel. We’re used to seeing the ...
Initial phase 1 dose escalation data for emiltatug ledadotin (Emi-Le), a novel B7-H4-directed dolasynthen antibody-drug conjugate. BMS-986504 in patients (pts) with advanced solid tumors with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback